These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18987483)

  • 21. The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.
    Tsai MC; Chen CH; Lee CM; Chen YT; Chien YS; Hung CH; Wang JH; Lu SN; Yen YH; Changchien CS; Hu TH
    J Hepatol; 2009 Feb; 50(2):281-8. PubMed ID: 19070392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double point mutation in the core promoter region of hepatitis B virus (HBV) genotype C may be related to liver deterioration in patients with chronic HBV infection.
    Nakashima H; Furusyo N; Kubo N; Kashiwagi K; Etoh Y; Kashiwagi S; Hayashi J
    J Gastroenterol Hepatol; 2004 May; 19(5):541-50. PubMed ID: 15086598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in the functional domain of basal core promoter of hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population.
    Biswas A; Banerjee A; Chandra PK; Datta S; Panigrahi R; Dutta D; De BK; Pal M; Guha SK; Chakrabarti S; Chakravarty R
    J Med Virol; 2011 Feb; 83(2):253-60. PubMed ID: 21181919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and molecular characterization of chronic hepatitis B in Albania: a country that is still highly endemic for HBV infection.
    Kondili LA; Brunetto MR; Maina AM; Argentini C; Chionne P; La Sorsa V; Resuli B; Mele A; Rapicetta M
    J Med Virol; 2005 Jan; 75(1):20-6. PubMed ID: 15543588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
    Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.
    Zeng G; Wang Z; Wen S; Jiang J; Wang L; Cheng J; Tan D; Xiao F; Ma S; Li W; Luo K; Naoumov NV; Hou J
    J Viral Hepat; 2005 Nov; 12(6):609-17. PubMed ID: 16255762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
    Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
    J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation.
    Tsai WL; Lo GH; Hsu PI; Lai KH; Lin CK; Chan HH; Chen WC; Cheng JS; Liu YC; Huang TS; Ger LP; Lin HH
    Scand J Gastroenterol; 2008; 43(2):196-201. PubMed ID: 18224565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
    Hou J; Schilling R; Janssen HL; Hansen BE; Heijtink R; Sablon E; Williams R; Lau GK; Schalm SW; Naoumov NV
    J Med Virol; 2007 Aug; 79(8):1055-63. PubMed ID: 17596838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.
    Yuan HJ; Ka-Ho Wong D; Doutreloigne J; Sablon E; Lai CL; Yuen MF
    J Infect; 2007 May; 54(5):497-503. PubMed ID: 16997379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology and transmission of hepatitis B virus in close family contacts of HBV-related chronic liver disease patients.
    Thakur V; Kazim SN; Guptan RC; Malhotra V; Sarin SK
    J Med Virol; 2003 Aug; 70(4):520-8. PubMed ID: 12794713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of the genotype and core promoter/pre-core mutations in hepatitis B virus carriers.
    Hagiwara S; Kudo M; Minami Y; Chung H; Nakatani T; Fukunaga T; Osaki Y; Yamashita Y; Kajimura K
    Intervirology; 2006; 49(4):200-6. PubMed ID: 16407657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.
    Yuen MF; Tanaka Y; Mizokami M; Yuen JC; Wong DK; Yuan HJ; Sum SM; Chan AO; Wong BC; Lai CL
    Carcinogenesis; 2004 Sep; 25(9):1593-8. PubMed ID: 15090469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
    Asim M; Malik A; Sarma MP; Polipalli SK; Begum N; Ahmad I; Khan LA; Husain SA; Akhtar N; Husain S; Thayumanavan L; Singla R; Kar P
    J Med Virol; 2010 Jul; 82(7):1115-25. PubMed ID: 20513073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
    Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese.
    Song LH; Duy DN; Binh VQ; Luty AJ; Kremsner PG; Bock CT
    J Viral Hepat; 2005 Mar; 12(2):160-7. PubMed ID: 15720531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.